Transcripts

Neumora Therapeutics (NMRA) earnings call transcripts

Earnings call transcripts for Neumora Therapeutics, Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q4 2025 earnings call

    Management framed 2026 around several clinical catalysts, while emphasizing that NMRA 215’s unexpected rat findings delay its path to the clinic.

    Date n/aPositive0.48